Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
New England Journal of Medicine · 28.11.2024 · 391 (21) · 2014-2026
DOI: 10.1056/nejmoa2402141 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 28.11.2024. Verfasst von Thierry Andre und 27 weiteren Autor:innen. Beteiligte Einrichtung: From Sorbonne Université, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Unité Mixte de Recherche Scientifique 938, and SIRIC CURAMUS,…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Colorectal Neoplasms, Ipilimumab, Nivolumab. Die Arbeit wurde bisher 310-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Bristol-Myers Squibb, Bristol Myers Squibb.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Sorbonne Université, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Unité Mixte de Recherche Scientifique 938, and SIRIC CURAMUS, Paris (T.A.), Hopital Foch, Suresnes (J.B.), and Institut Paoli-Calme…
ORCID-Profile: Myriam Chalabi
Förderung
- Bristol-Myers Squibb
- Bristol Myers Squibb
Zitieren
APA
Andre, T., Elez, E., Van Cutsem, E., Jensen, L. H., Bennouna, J., Mendez, G., Schenker, M., de la Fouchardiere, C., Limon, M. L., Yoshino, T., Li, J., Lenz, H. J., Manzano Mozo, J. L., Tortora, G., Garcia-Carbonero, R., Dahan, L., Chalabi, M., Joshi, R., Goekkurt, E., …, & CheckMate 8HW Investigators (2024). Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer. New England Journal of Medicine, 391(21), 2014-2026. https://doi.org/10.1056/nejmoa2402141
Vancouver
Andre T, Elez E, Van Cutsem E, Jensen LH, Bennouna J, Mendez G, et al. Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer. New England Journal of Medicine. 2024;391(21):2014-2026. doi:10.1056/nejmoa2402141
BibTeX
@article{Andre2024,
author = {Andre, Thierry and Elez, Elena and Van Cutsem, Eric and Jensen, Lars Henrik and Bennouna, Jaafar and Mendez, Guillermo and Schenker, Michael and de la Fouchardiere, Christelle and Limon, Maria Luisa and Yoshino, Takayuki and Li, Jin and Lenz, Heinz-Josef and Manzano Mozo, Jose Luis and Tortora, Giampaolo and Garcia-Carbonero, Rocio and Dahan, Laetitia and Chalabi, Myriam and Joshi, Rohit and Goekkurt, Eray and Braghiroli, Maria Ignez and Cil, Timucin and Cela, Elvis and Chen, Tian and Lei, Ming and Dixon, Matthew and Abdullaev, Sandzhar and Lonardi, Sara and CheckMate 8HW Investigators, CheckMate 8HW Investigators},
title = {Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {21},
pages = {2014--2026},
doi = {10.1056/nejmoa2402141}
}
EUVIMED